CD45 (pY1216) Blocking Peptide
The peptide is used to block Anti-CD45 (pY1216) Antibody (#CPA5517) reactivity.
| Supplier | Cohesion Biosciences |
|---|---|
| Product # | CBP5517 |
| Pricing | 1 mg USD $150.0, 5 mg USD $450.0 |
| Source | Synthetic |
| Reactivity | H, M, R |
| Applications | BL |
| Delivery Time | Ship in 3 weeks |
| Form | Lyophilized powder |
| Gene Symbol | PTPRC |
| Entrez Gene (Human) | 5788.0 |
| Entrez Gene (Rat) | 24699.0 |
| SwissProt (Human) | P08575 |
| SwissProt (Mouse) | P06800 |
| SwissProt (Rat) | P04157 |
| Purity | >85% |
| Quality Control | The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. |
| Directions for Use | Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours. |
| Storage/Stability | Shipped at 4°C. Store at -20°C for one year. |
| Datasheet | http://www.cohesionbio.com/download/CBP5517.pdf |